Targeting chemoattractant chemokine (c-c motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders

HIGHLIGHTS

• who: Yupeng Wang from the Chinese Academy of Medical Sciences, China Nanjing University, China have published the Article: Targeting chemoattractant chemokine (C-C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders, in the Journal: (JOURNAL)
• what: In this study, lesion volumes were evaluated in live mice on day 3 after NMO-IgG injection using 7.0-T small-animal MRI. In the present study, CCL2 showed the sharpest increase out of all the cytokines detected (p and amp;lt; 0.001). In the present . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.